Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Bausch Health gets new chair

By Brian Buntz | June 27, 2022

Bausch HealthThe chair of Bausch Health (NYSE:BHC), Joe Papa, has resigned. The company has named the billionaire hedge fund manager John Paulson to assume the role.

In an announcement, Bausch Health noted that the decision for Papa to resign was “not due to any dispute or disagreement” with the company or board.

In May, Bausch Health spun out its eye care unit Bausch + Lomb Corp. (NYSE/TSX:BLCO). BHC stock has fallen steadily since, losing about half its value in the past two months.

“The Company and the Board of Directors would like to thank Mr. Papa for his leadership over the past six years. Joe oversaw significant change in the business during his tenure, and we appreciate his role in Bausch Health’s continued transformation,” said CEO Thomas J. Appio in a statement. “I am excited about the Company’s future and its potential to create shareholder value,” added John Paulson.

Because Paulson is an independent director, Bausch Health will no longer have a lead independent director position on its board.

Paulsen has served on the Bausch + Lomb board from June 2017 to May 2022.

Bausch Health had planned to spin off its Solta Medical aesthetics unit via an IPO but has changed its mind as the economy slows.

In the first quarter of 2022, Bausch reported $1.92 billion in revenue — a 5.4% dip year over year.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Biogen logo
Biogen is scaling back space outside Boston
Fresenius Kabi
Fresenius Kabi plans to add 2D barcodes to its pharmaceutical portfolio
Dollars for drugs
Democrats’ drug pricing plan attracts pushback from Republicans
GBT/Pfizer
Pfizer to scoop up Global Blood Therapeutics for $5.4 billion 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards